# Utility of Squamous Cell Carcinoma Antigen (SCCA) in Psoriasis

> **NCT04308616** · — · COMPLETED · sponsor: **University Hospital, Tours** · enrollment: 51 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **OTHER:** Blood samples

## Key facts

- **NCT ID:** NCT04308616
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-20
- **Primary completion:** 2022-04-27
- **Final completion:** 2022-04-27
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04308616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04308616, "Utility of Squamous Cell Carcinoma Antigen (SCCA) in Psoriasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04308616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*